The Annual Secretarial Compliance Report for the year ended March 31, 2025 issued by Ms. Prajakta V. Padhye, Partner of Nilesh A. Pradhan & Co. LLP , Practising Company Secretaries, Mumbai
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as mandated under Regulation 24A of the SEBI Listing Regulations. The report was prepared by Ms. Prajakta V. Padhye, Partner of Nilesh A. Pradhan & Co., LLP, Practicing Company Secretaries. The review covered compliance with SEBI Act, SCRA, Listing Regulations, Insider Trading Regulations, and various other SEBI circulars and guidelines. The auditor confirmed full compliance across all 13 areas examined, including secretarial standards, board policies, website disclosures, director eligibility, related party transactions, and insider trading norms. No non-compliances, deviations, or adverse actions by SEBI or stock exchanges were reported during the review period. The company also has no subsidiaries and no events of statutory auditor resignation to report.
This is a routine annual compliance filing with a clean report and no adverse observations, reflecting sound corporate governance practices. It is unlikely to have any material impact on the stock price, though it reassures investors about regulatory adherence.